期刊文献+

L-精氨酸对人凝血因子Ⅷ基因表达的影响 被引量:2

Effect of L-argnine on human coagulant factor Ⅷ gene expression
原文传递
导出
摘要 目的研究L-精氨酸对人凝血因子Ⅷ(FⅧ)基因转录及表达的影响。方法将B结构域(氨基酸760~1639)缺失的人FⅧcDNA(BDDhFⅧcDNA)插入至质粒载体pcDNA6/V5-HisA,构建重组载体pcDNA6/V5-HisA-BDDhFⅧ,转染人脐静脉内皮细胞(HUVEC),加入L-精氨酸(终浓度10mmol/L)培养72h后,用ELISA方法检测细胞上清液中的人FⅧ抗原(FⅧ:Ag),一期凝血酶法检测FⅧ的促凝活性(FⅧ:C)。用Northern blot检测HUVEC中人FⅧ基因的转录。用PCR扩增BDDhFⅧcDNA的A1、A2、A3、C1和C2结构域基因,分别插入至pcDNA6/V5-HisA,构建五种载体pcDNA6/V5-HisA-BDDhFⅧ-A1、pcDNA6/V5-BDDhF Ⅷ-A2、pcDNA6/V5-HisA-BDDhF Ⅷ-A3、pcDNA6/V5-HisA-BDDhF Ⅷ-C1和pcDNA6/V5-HisA-BDDhF Ⅷ-C2,分别转染HUVEC后,加入L-精氨酸(终浓度10mmol/L)培养72h。膨胀裂解法分离细胞核,进行细胞核连缀(Run-on)反应,狭线印迹杂交检测A1、A2、A3、C1和C2结构域基因的转录。结果经L-精氨酸诱导后,HUVEC中人FⅧ基因表达明显增强[FⅧ:Ag为(146.08±4.78)ng/ml,10^6细胞诱导24h后FⅧ:C为(0.752±0.009)U/ml],约是未经L-精氨酸诱导[FⅧ:Ag为(34.66±3.98)ng/ml,10^6细胞诱导24h后FⅧ:C为(0.171±0.006)U/ml]的4倍(P〈0.01)。Northern blot检测显示,加L-精氨酸培养之后,HUVEC中人BDDFⅧ mRNA的转录也较未加L-精氨酸显著增强,而只转染pcDNA6/V5-HisA的HUVEC中无人BDDFⅧ mRNA的转录存在。Run-on及狭线印迹杂交显示,加L-精氨酸培养后,A1和A2结构域基因的转录均较未经L-精氨酸诱导者明显增强,也显著强于A3、C1和C2结构域基因的转录,而A3、C1和C2结构域基因的转录在L-精氨酸诱导前后均无明显变化。结论L-精氨酸通过促进人FⅧ的A1和A2结构域基因的转录进而增强FⅧ在体外的转录和表达,因而在血友病A的基因治疗研究中,L-精氨酸是一个很有前途的诱导FⅧ转录和表达的物质。 Objective To investigate the effect of L-arginine on expression of human FⅧ gene. Methods Plasmid pcDNA6/VS-HisA-BDDhFⅧ containing B domain deleted human coagulant factor Ⅷ cDNA (BDDhF Ⅷ cDNA ) was constructed and transfected into human umbilical vein endothelial cells (HUVEC). After 72 h incubation with L-arginine (final concentration was 10 mmol/L) , the supernant was collected for determining the antigen and clotting activity of human FⅧ ( FⅧ: Ag and FⅧ: C ) with ELISA and one stage clotting assay respectively. HUVECs were harvested for detecting human FⅧ mRNA by Northern blot analysis. The five functional domains of BDDhFⅧ cDNA including A1, A2, A3, C1 and C2 were amplified with PCR and inserted into pcDNA6/V5-HisA to construct the expression plasmids pcDNA6/V5-Hi- sA-BDDhFⅧ-A1, pcDNA6/V5-HisA-BDDhF Ⅷ-A2, pcDNA6/V5-HisA-BDDhF Ⅷ-A3, pcDNA6/V5-HisA-BDDhFⅧ-C1 and pcDNA6/V5-HisA-BDDhFⅧ-C2, respectively. HUVEC were transfected with the five plasmids respectively and incubated with L-arginine (at the final concentration of 10 mmol/L) for 72 h. Nueleoli were then isolated and underwent run-on assay. Results After 24 h incubation with L-arginine, FⅧ: Ag and FⅧ: C were increased markedly in the supernant of HUVEC [ FⅧ:Ag was (146.08 ±4.78 ) ng/ ml, and FⅧ: C (0. 752±0. 009) U/mL/10^6 cells · 24 h, while in control supernant without L-arginine, FⅧ: Agwas (34.66±3.98) ng/ml, and FⅧ: C (0. 171 ±0.006) U/mL/10^6 cell · 24 h, P〈0.01]. Northern blot analysis indicated that, after adding L-arginine, the transcription of human FⅧ mRNA was intensified remarkably in HUVEC transfected with pcDNA6/VS-HisA-BDDhFⅧ, but no any transcription in those transfected with pcDNA6/VS-HisA. Run-on assay demonstrated that with L-arginine induction, A1 and A2 domains transcription was increased obviously, while no change in A3, C1 and C2 domains transcription. Conclusion L-arginine increases expression of human FⅧ gene in HUVEC through enhancing its transcrip tion, particularly, domain A1 and A2 within FⅧ gene.
出处 《中华血液学杂志》 CAS CSCD 北大核心 2007年第3期178-183,共6页 Chinese Journal of Hematology
基金 广东省自然科学基金资助项目(034622)
关键词 L-精氨酸 凝血因子Ⅷ 内皮细胞 脐静脉 基因表达 L-arginine Coagulant factor Ⅷ Endothelial cells, human umbilical vein Gene expression
  • 相关文献

参考文献15

  • 1Lee JW. yon Willebrand disease, hemophilia A and B, and other factor deficiencies, Int Anesthesiol Clin, 2004, 42:59-76.
  • 2Stobart K, Iorio A, Wu JK. Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B. Cochrane Database Syst Rev, 2006, 2:CD003429.
  • 3Yee TT, Lee CA. Transfusion-transmitted infection in hemophilia in developing countries. Semin Thromb Hemost, 2005, 31 : 527-537.
  • 4Ananyeva NM, Lacroix-Desmazes S, Hauser CA, et al. Inhibitors in hemophilia A: mechanisms of inhibition, management and perspectives. Blood Coagul Fibrinolysis, 2004, 15: 109-124.
  • 5Nathwani AC, Nienhuis AW, Davidoff AM. Current status of gene therapy for hemophilia. Curr Hematol Rep, 2003, 2: 319-327.
  • 6尹俊,郑庆棠,谢舜峰,刘幸平.反义寡脱氧核苷酸对内皮细胞缺氧再复氧损伤组织因子表达的影响[J].血栓与止血学,2005,11(3):101-105. 被引量:2
  • 7Chen C, Fang XD, Zhu J, et al. The gene expression of coagulation factor Ⅷ in mammalian cell lines. Thromb Res, 1999,95 : 105-115.
  • 8尹俊,王鸿利,王学锋,璩斌,武文漫,丁秋兰,傅启华,戚正武,王振义.非病毒载体介导的人凝血因子Ⅷ基因在小鼠32D细胞系中的表达[J].中国实验血液学杂志,2004,12(6):721-725. 被引量:6
  • 9尹俊,王鸿利.人凝血因子Ⅷ基因表达调控的研究[J].国外医学(输血及血液学分册),2002,25(1):35-37. 被引量:5
  • 10Sandberg H, Almstedt A, Brandt J, et al. Structural and functional characteristics of the B-domain-deleted recombinant factor Ⅷ protein, r-Ⅷ SQ. Thromb Haemost, 2001, 85 : 93-100.

二级参考文献69

  • 1[21]Versteeg HH. Tissue factor as an evolutionary conserved cytokine receptor: Implications for inflammation and signal transduction[J]. Semin Hemato1,2004 ,41 ( 1 Suppl 1 ): 168 ~ 172.
  • 2[22]Pyo RT, Sato Y, Mackman N, et al. Mice deficient in tissue factor demonstrate attenuated intimal hyperplasia in response to vascular injury and decreased smooth muscle cell migration[ J]. Thromb Haemost ,2004,92(3) :451 ~458.
  • 3[23]Penn MS, Topol EJ . Tissue factor, the emerging link between inflammation, thrombosis, and vascular remodeling [ J ]. Circ Res,2001,89(1) :1 ~2.
  • 4[1]Luther T, Mackman N. Tissue factor in the heart . Multiple roles in hemostasis, thrombosis , and inflammation [ j ] . Trends Cardiovasc Med,2001,11(8) :307 ~312.
  • 5[2]Deo DD, Bazan NG, Hunt JD. Activation of platelet-activating factor receptor-coupled G alpha q ledds to stimulation of Src and focal adhesion kinase via two separate pathweys in human umbilical vein ednothelial cells[j]. J Biol Chem,2004,279(5) :3497 ~3508.
  • 6[3]Vallet B, Wiel E. Endothelial cell dysfunction and coagulation [J]Crit Care Med,2001,29(7 Suppl) :S36 ~41.
  • 7[4]Szmitko PE, Wang CH, Weisel RD, et al . New markers of inflammation and endothelial cell activation [ J ]. Part I . Circulation, 2003,108(16) :1917 ~ 1923.
  • 8[5]McLeod LL, Sevanian A. Lipid peroxidation and modification of lipid composition in an endothelial cell model of ischemia and reperfusion[J]. Free Radic Biol Med,1997,23(4) :680 ~694.
  • 9[6]Zweier JL. Free radical generation in human endothelial cells exposed to anoxia and reoxygenation [J]. Transplant Proc, 1998,30 ( 8 ):4228 ~ 4232.
  • 10[7]Yee SB,Hanumegowda UM,Copple BL,et al. Endothelial cell injury and coagulation system activation during synergistic hepatotoxicity from monocrotaline and bacterial lipopolysaccharide coexposure [J].Toxicol Sci,2003,74( 1 ) :203 ~214.

共引文献9

同被引文献20

  • 1尹俊,王鸿利,王学锋,璩斌,武文漫,丁秋兰,傅启华,戚正武,王振义.非病毒载体介导的人凝血因子Ⅷ基因在小鼠32D细胞系中的表达[J].中国实验血液学杂志,2004,12(6):721-725. 被引量:6
  • 2尹俊,郑庆棠,谢舜峰,刘幸平.反义寡脱氧核苷酸对内皮细胞缺氧再复氧损伤组织因子表达的影响[J].血栓与止血学,2005,11(3):101-105. 被引量:2
  • 3Lee JW. yon Willebrand disease, hemophilia A and B, and other factor deficiencies [J]. Int Anesthesiol Clin, 2004, 42(3): 59-76.
  • 4Stobart K, Iorio A, Wu JK. Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B [J]. Coehrane Database Syst Rev, 2005, 18(2): CD003429.
  • 5Yee Tr, Lee CA. Transfusion-transmitted infection in hemophilia in developing countries [J]. Semin Thromb Hemost, 2005, 31(5): 527-537.
  • 6Roosendaal G, Lafeber F. Prophylactic treatment for prevention of joint disease in hemophilia-cost versus benefit [J]. N Engl J Med, 2007, 357(6): 603-605.
  • 7Parker ET, Doering CB, Lollar P. A1 subunit-mediated regulation of thrombin-activated factor Ⅷ A2 subunit dissociation[J]. J Biol Chem, 2006, 281(20): 13922-13930.
  • 8Ngo JC, Huang M, Roth DA, et al. Crystal structure of human factor Ⅷ: implications for the formation of the factor Ⅸa-factor Ⅷa complex[J]. Structure, 2008, 16(4): 597-606.
  • 9Sandberg H, Almstedt A, Brandt J, et al. Structural and functional characteristics of the B-domain-deleted recombinant factor Ⅷ protein, r-Ⅷ SQ[J]. Thromb Haemost, 2001, 85(1): 93-100.
  • 10Giannakis G, Edmondson SR, Favaloro JM, et al. Aberrant cryptic responsiveness of the pCAT 3- and pGL3- promoter reporter vectors[J]. Bioteehniques, 2003, 35(2): 332-339.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部